These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3119206)

  • 1. Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas.
    Quirt I; Eisenhauer E; Bramwell V; Knowling M; Grafton C; Hirte W; Cripps M; Maksymiuk A
    Cancer Treat Rep; 1987 Nov; 71(11):1109-10. PubMed ID: 3119206
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
    Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
    Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
    Nielsen OS; Reichardt P; Christensen TB; Pink D; Daugaard S; Hermans C; Marreaud S; van Glabbeke M; Blay J; Judson I
    Eur J Cancer; 2006 Sep; 42(14):2303-9. PubMed ID: 16891112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH; Montella D; Rosenbaum C; Schwen M
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of mitoxantrone for acute leukemia].
    Oguma S; Tatsumi Y; Hirayama F; Tani Y; Kubota Y; Kanakura Y; Ueda T; Nakamura H; Shibata H; Masaoka T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):497-501. PubMed ID: 6703723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.
    Alberts DS; Surwit EA; Peng YM; McCloskey T; Rivest R; Graham V; McDonald L; Roe D
    Cancer Res; 1988 Oct; 48(20):5874-7. PubMed ID: 3167842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
    Hørding U; Rose C; Jakobsen K; Dirksen H
    Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
    Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
    Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
    Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
    Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Kito M; Umeda T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
    Tursz T
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of mitoxantrone in epithelial ovarian cancer.
    Lawton F; Blackledge G; Mould J; Latief T; Watson R; Chetiyawardana AD
    Cancer Treat Rep; 1987 Jun; 71(6):627-9. PubMed ID: 3581101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.